Back
PubMedClinical pipelineBenchmark

Expanding the genetic spectrum of neurogenetic disorders in Moroccan families by exome sequencing.

(authors to verify via PubMed)Mol Biol Rep 2026 · May 2026
Relevance score
7/10
Disease / domain
Rare neurogenetic disorders in Moroccan families — exome diagnosis and expanded genetic spectrum
Source
PubMed
PMID 42113100
Share on LinkedIn

Tool / method

Exome sequencing of consanguineous Moroccan families — identification of pathogenic variants in known genes and novel candidate genes for NDD and neurodegenerative diseases

Summary

Exome sequencing is applied to consanguineous Moroccan families with neurogenetic disorders, identifying pathogenic variants in known genes and potentially novel candidate genes. North African populations are severely underrepresented in clinical genomics studies despite high consanguinity rates that facilitate rare recessive variant discovery. This work expands the accessible diagnostic genetic spectrum for this underserved population. ⚠️ Summary based on title (metadata verification needed).

Synthesis written by Geno'X. For the full original abstract, please refer to the source publication.

Analysis

Consanguineous North African families offer unique opportunities for recessive gene discovery: the high probability of homozygous-by-descent variants simplifies pathogenicity demonstration. Each exome study in these populations fills a real knowledge gap applicable to patients who often remain undiagnosed.

Why this score?

Clinical impact : 2/3 · Evidence strength : 2/3 · Novelty : 2/2 · Sample size : 1/1 · Journal quality : 0/1 → Total : 7/10

Keywords

exomeneurogenetic disordersMoroccoconsanguinitygenetic spectrum
Weekly report in your inbox

Every Wednesday · Annotated selection · Free · Unsubscribe anytime